drugset / Trial / NCT04145856
Combination of Alverine-simeticone and i3.1 Probiotic in IBS-D and IBS-M in Mexico
RandomizedParallel-groupSingle-blindTreatment
Summary
This randomized study evaluates the usefulness of the I31 probiotic formula, alone or in combination with alverine/simethicone, against placebo, in the treatment of diarrhea-predominant or mixed irritable bowel syndrome
Timeline
- Start
- 2018-09-03
- Primary completion
- 2019-05-02
- Completion
- 2019-08-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alverine | Small molecule | 60 mg | — |
| Subject | Floradapt Intensive GI | Unknown | 3e+09 unknown | — |
| Subject | Simethicone | Other / unclassified | 300 mg | Oral |